OMALIZUMAB News

← Back to News Overview


OMALIZUMAB currently has 0 news articles, with 14 predicted indications.

This page combines the AI-predicted indications for OMALIZUMAB with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
  • Evidence level: L5
  • Predicted indications (14):
    • asthma (99.0%)
    • idiopathic urticaria (99.0%)
    • intrinsic asthma (99.0%)
    • allergic asthma (99.0%)
    • bronchitis (100.0%)
    • atopic eczema (100.0%)
    • obstructive lung disease (100.0%)
    • dermatitis (100.0%)
    • bronchial neoplasm (disease) (100.0%)
    • acne keloid (99.9%)
    • acrodermatitis chronica atrophicans (99.9%)
    • hydroa vacciniforme, familial (99.9%)
    • neonatal dermatomyositis (99.9%)
    • secondary interstitial lung disease specific to childhood associated with a connective tissue disease (99.9%)

View full drug report →

No related news yet. When news mentions this drug, it will be collected and shown here automatically.

Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.

Copyright © 2026 藥提醒科技有限公司 (yao.care). For research purposes only. Not medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.